BENZIMIDAZOLONE DERIVATIVES HAVING MIXED SEROTONINE AND DOPAMINE RECEPTORS AFFINITY
申请人:BOEHRINGER INGELHEIM ITALIA S.p.A.
公开号:EP1218352A1
公开(公告)日:2002-07-03
US6281218B1
申请人:——
公开号:US6281218B1
公开(公告)日:2001-08-28
[EN] NEW BENZIMIDAZOLONE DERIVATIVES HAVING MIXED SEROTONINE AND DOPAMINE RECEPTORS AFFINITY<br/>[FR] NOUVEAUX DERIVES DE BENZIMIDAZOLONE POSSEDANT UNE AFFINITE MIXTE ENVERS LES RECEPTEURS DE SEROTONINE ET DE DOPAMINE
申请人:BOEHRINGER INGELHEIM ITALIA
公开号:WO2001021593A1
公开(公告)日:2001-03-29
The present invention pertains to compounds of general formula (I) wherein R1, R2, R3, and R4 denote hydrogen or hydroxy with the proviso that R1, R2, R3, and R4 cannot simultaneously represent hydrogen. These compounds bind to the Serotonine and dopamine receptors and are useful in the treatment of CNS disorders.